Semaglutide is linked with a rare form of vision loss called non-arteritic anterior ischemic optic neuropathy (NAION). That’s ...

A new study has linked the active ingredient in Novo Nordisk's Ozempic and Wegovy, to an eye condition that can cause ...

Whether they were treated or not, return visits to the doctor for pink eye were rare, under 4%, according to the study published Thursday in the journal JAMA Ophthalmology. Doctor's offices gave ...

they wrote in JAMA Ophthalmology. Over 3 years, the cumulative incidence of NAION were 8.9% and 6.7% in the two semaglutide groups, respectively, versus 1.8% and 0.8% for the non-GLP-1 groups.

Study suggests Semaglutide a popular antidiabetic drug may be linked to vision loss Learn about the potential risks and ...

In a news release published Monday on the results of the latest JAMA Ophthalmology study, the AAO noted that previous studies have linked semaglutide to blurred vision, worsening of diabetic ...

But the Mayo Clinic ophthalmologist who presented the findings stressed that it was “hugely reassuring” the GLP-1s were ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Patients taking semaglutide may be at an increased risk for an eye condition that can cause vision loss, according to a study published in JAMA Ophthalmology. The authors emphasized that more research ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Insurance claims data showed that patients with autoimmune ...

More information: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide, JAMA Ophthalmology (2024). DOI: 10.1001/jamaophthalmol.2024.2296 Journal information ...